SCD and cancer: Also, our results provide evidence that DNA damage induces a downregulation in the expression of ACSL3 and SCD1, both involved in fatty acid metabolism, which is often dysregulated in highly proliferative and cancer cells [37, 38], unlike what happens with the case of the MVK and SCD5 enzymes that have not been related to cancer prognosis [39].